Travere Therapeutics, Inc. 2.25% 01-MAR-2029Travere Therapeutics, Inc. 2.25% 01-MAR-2029Travere Therapeutics, Inc. 2.25% 01-MAR-2029

Travere Therapeutics, Inc. 2.25% 01-MAR-2029

No trades
See on Supercharts

RTRX5376243 analysis



Key facts


Issue date
Mar 11, 2022
Maturity date
Mar 1, 2029
Outstanding amount
‪316.25 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
2.25% (Fixed)
Yield to maturity
3.26%
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.